Articles citing this paper
Sialyltransferase Inhibitors as Potential Anti-Cancer Agents*
Danielle Skropeta
A B C , Christopher Dobie A , Andrew P. Montgomery A , Harrison Steele A , Rémi Szabo A and Haibo Yu A B
+ Author Affiliations
- Author Affiliations
A Molecular Horizons and School of Chemistry and Molecular Bioscience, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia.
B Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
C Corresponding author. Email: skropeta@uow.edu.au
Australian Journal of Chemistry 74(11) 758-766 https://doi.org/10.1071/CH21195
Submitted: 12 August 2021 Accepted: 8 October 2021 Published: 22 November 2021
5 articles found in Crossref database.
The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases
Harduin-Lepers Anne
Glycoconjugate Journal. 2023 40(4). p.473
Glycosyltransferases as targets for therapeutic intervention in cancer and inflammation: molecular modeling insights
Tvaroška Igor
Chemical Papers. 2022 76(4). p.1953
Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review
Al Saoud Ranim,
Hamrouni Amar,
Idris Adi,
Mousa Walaa K., Abu Izneid Tareq
Biomedicine & Pharmacotherapy. 2023 165 p.115091
Synthesis of α‐Hydroxy‐1,2,3‐Triazole‐linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2
Szabo Rémi,
Dobie Chris,
Montgomery Andrew P.,
Steele Harrison,
Yu Haibo, Skropeta Danielle
ChemMedChem. 2024
Celebrating RACI and Academy of Science Awards 2020–2021
Wentrup Curt
Australian Journal of Chemistry. 2021 74(11). p.747
